# Genie Energy Ltd.: financial statements, quarterly

GNE · NYSE · CIK 1528356 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gne.md) · [Financials](/companies/gne/financials.md) · [Filings](/companies/gne/filings.md) · [Insiders](/companies/gne/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gne/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [125](/filings/0001437749-26-014294.md) | [105](/filings/0001437749-26-014294.md) | [120](/filings/0001437749-26-014294.md) | [90.7](/filings/0001437749-26-014294.md) | [112](/filings/0001437749-26-014294.md) | [103](/filings/0001437749-26-014294.md) | [137](/filings/0001437749-26-017292.md) | [105](/filings/0001437749-26-026209.md) | [138](/filings/0001437749-26-014294.md) | [121](/filings/0001437749-26-014294.md) | [142](/filings/0001437749-26-017292.md) | [100](/filings/0001437749-26-026209.md) |
| Cost of revenue | $m | [84.0](/filings/0001437749-26-014294.md) | [71.3](/filings/0001437749-26-014294.md) | [85.9](/filings/0001437749-26-014294.md) | [57.4](/filings/0001437749-26-014294.md) | [74.0](/filings/0001437749-26-014294.md) | [69.4](/filings/0001437749-26-014294.md) | [99.4](/filings/0001437749-26-017292.md) | [81.8](/filings/0001437749-26-026209.md) | [108](/filings/0001437749-26-014294.md) | [87.8](/filings/0001437749-26-014294.md) | [112](/filings/0001437749-26-017292.md) | [66.7](/filings/0001437749-26-026209.md) |
| Gross profit | $m | [41.1](/filings/0001213900-24-095312.md) | [33.6 d](/filings/0001437749-26-014294.md) | [33.8](/filings/0001213900-25-041331.md) | [33.3](/filings/0001437749-25-025334.md) | [37.9](/filings/0001437749-25-033534.md) | [33.5 d](/filings/0001437749-26-014294.md) | [37.4](/filings/0001437749-26-017292.md) | [23.5](/filings/0001437749-26-026209.md) | [30.0](/filings/0001437749-25-033534.md) | [33.8 d](/filings/0001437749-26-014294.md) | [29.8](/filings/0001437749-26-017292.md) | [33.7](/filings/0001437749-26-026209.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [23.2](/filings/0001213900-24-095312.md) | [22.7 d](/filings/0001437749-26-014294.md) | [22.9](/filings/0001213900-25-041331.md) | [22.0](/filings/0001437749-25-025334.md) | [25.2](/filings/0001437749-25-033534.md) | [23.3 d](/filings/0001437749-26-014294.md) | [23.9](/filings/0001437749-26-017292.md) | [21.2](/filings/0001437749-26-026209.md) | [22.6](/filings/0001437749-25-033534.md) | [27.6 d](/filings/0001437749-26-014294.md) | [27.9](/filings/0001437749-26-017292.md) | [27.1](/filings/0001437749-26-026209.md) |
| Operating income | $m | [17.9](/filings/0001213900-25-024009.md) | [(34.2)](/filings/0001213900-25-024009.md) | [9.8](/filings/0001213900-25-041331.md) | [10.6](/filings/0001437749-25-025334.md) | [11.7](/filings/0001437749-25-033534.md) | [(20.8)](/filings/0001213900-25-024009.md) | [13.5](/filings/0001437749-26-017292.md) | [2.3](/filings/0001437749-26-026209.md) | [6.9](/filings/0001437749-25-033534.md) | [4.6](/filings/0001437749-26-014294.md) | [1.9](/filings/0001437749-26-017292.md) | [6.5](/filings/0001437749-26-026209.md) |
| Interest expense | $m | not reported | not reported | not reported | [0.3](/filings/0001437749-25-025334.md) | [0.0](/filings/0001437749-25-033534.md) | [0.1 d](/filings/0001437749-26-014294.md) | [0.2](/filings/0001437749-26-017292.md) | [0.2](/filings/0001437749-26-026209.md) | [0.2](/filings/0001437749-25-033534.md) | [0.2 d](/filings/0001437749-26-014294.md) | [0.1](/filings/0001437749-26-017292.md) | [0.1](/filings/0001437749-26-026209.md) |
| Income tax | $m | [5.0](/filings/0001213900-24-095312.md) | [3.7 d](/filings/0001437749-26-014294.md) | [2.9](/filings/0001213900-25-041331.md) | [3.5](/filings/0001437749-25-025334.md) | [3.9](/filings/0001437749-25-033534.md) | [5.0 d](/filings/0001437749-26-014294.md) | [5.2](/filings/0001437749-26-017292.md) | [1.8](/filings/0001437749-26-026209.md) | [2.5](/filings/0001437749-25-033534.md) | [0.3 d](/filings/0001437749-26-014294.md) | [1.6](/filings/0001437749-26-017292.md) | [0.2](/filings/0001437749-26-026209.md) |
| Net income | $m | [14.5](/filings/0001213900-24-095312.md) | [(23.7)](/filings/0001213900-25-024009.md) | [8.1](/filings/0001213900-24-041190.md) | [9.6](/filings/0001437749-25-025334.md) | [10.2](/filings/0001437749-25-033534.md) | [(15.5)](/filings/0001213900-25-024009.md) | [10.4](/filings/0001437749-26-017292.md) | [2.3](/filings/0001437749-26-026209.md) | [6.7](/filings/0001437749-25-033534.md) | [4.8](/filings/0001437749-26-014294.md) | [2.8](/filings/0001437749-26-017292.md) | [11.4](/filings/0001437749-26-026209.md) |
| Diluted EPS | $ per share | [0.53](/filings/0001437749-26-014294.md) | [0.35](/filings/0001437749-26-014294.md) | [0.31](/filings/0001437749-26-014294.md) | [0.36](/filings/0001437749-26-014294.md) | [0.39](/filings/0001437749-26-014294.md) | [0.25](/filings/0001437749-26-014294.md) | [0.40](/filings/0001437749-26-017292.md) | [0.09](/filings/0001437749-26-026209.md) | [0.25](/filings/0001437749-26-014294.md) | [0.16](/filings/0001437749-26-014294.md) | [0.11](/filings/0001437749-26-017292.md) | [0.43](/filings/0001437749-26-026209.md) |
| Basic EPS | $ per share | [0.54](/filings/0001213900-25-024009.md) | [(0.93)](/filings/0001213900-25-024009.md) | [0.30](/filings/0001213900-25-041331.md) | [0.36](/filings/0001437749-25-025334.md) | [0.38](/filings/0001437749-25-033534.md) | [(0.57)](/filings/0001213900-25-024009.md) | [0.40](/filings/0001437749-26-017292.md) | [0.09](/filings/0001437749-26-026209.md) | [0.26](/filings/0001437749-25-033534.md) | [0.17](/filings/0001437749-26-014294.md) | [0.11](/filings/0001437749-26-017292.md) | [0.44](/filings/0001437749-26-026209.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [140](/filings/0001213900-23-084614.md) | [159](/filings/0001437749-26-014294.md) | [107](/filings/0001213900-24-041190.md) | [122](/filings/0001213900-24-066525.md) | [136](/filings/0001213900-24-095312.md) | [193](/filings/0001437749-26-014294.md) | [113](/filings/0001213900-25-041331.md) | [105](/filings/0001437749-25-025334.md) | [109](/filings/0001437749-25-033534.md) | [204](/filings/0001437749-26-026209.md) | [186](/filings/0001437749-26-017292.md) | [185](/filings/0001437749-26-026209.md) |
| Current assets | $m | [270](/filings/0001213900-23-084614.md) | [230](/filings/0001213900-25-024009.md) | [228](/filings/0001213900-24-041190.md) | [216](/filings/0001213900-24-066525.md) | [228](/filings/0001213900-24-095312.md) | [297](/filings/0001437749-26-014294.md) | [239](/filings/0001213900-25-041331.md) | [231](/filings/0001437749-25-025334.md) | [238](/filings/0001437749-25-033534.md) | [323](/filings/0001437749-26-026209.md) | [311](/filings/0001437749-26-017292.md) | [305](/filings/0001437749-26-026209.md) |
| Total assets | $m | [316](/filings/0001213900-23-084614.md) | [331](/filings/0001213900-25-024009.md) | [328](/filings/0001213900-24-041190.md) | [323](/filings/0001213900-24-066525.md) | [342](/filings/0001213900-24-095312.md) | [370](/filings/0001437749-26-014294.md) | [384](/filings/0001213900-25-041331.md) | [383](/filings/0001437749-25-025334.md) | [394](/filings/0001437749-25-033534.md) | [389](/filings/0001437749-26-026209.md) | [376](/filings/0001437749-26-017292.md) | [370](/filings/0001437749-26-026209.md) |
| Current liabilities | $m | [106](/filings/0001213900-23-084614.md) | [98.3](/filings/0001213900-25-024009.md) | [101](/filings/0001213900-24-041190.md) | [83.4](/filings/0001213900-24-066525.md) | [88.8](/filings/0001213900-24-095312.md) | [122](/filings/0001437749-26-014294.md) | [117](/filings/0001213900-25-041331.md) | [116](/filings/0001437749-25-025334.md) | [125](/filings/0001437749-25-033534.md) | [136](/filings/0001437749-26-026209.md) | [122](/filings/0001437749-26-017292.md) | [106](/filings/0001437749-26-026209.md) |
| Total liabilities | $m | [108](/filings/0001213900-23-084614.md) | [146](/filings/0001213900-25-024009.md) | [149](/filings/0001213900-24-041190.md) | [133](/filings/0001213900-24-066525.md) | [141](/filings/0001213900-24-095312.md) | [135](/filings/0001437749-26-014294.md) | [197](/filings/0001213900-25-041331.md) | [196](/filings/0001437749-25-025334.md) | [205](/filings/0001437749-25-033534.md) | [145](/filings/0001437749-26-026209.md) | [131](/filings/0001437749-26-017292.md) | [114](/filings/0001437749-26-026209.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [8.7](/filings/0001437749-26-014294.md) | [6.8](/filings/0001213900-25-041331.md) | [6.8](/filings/0001437749-25-025334.md) | [6.7](/filings/0001437749-25-033534.md) | [6.5](/filings/0001437749-26-026209.md) | [6.5](/filings/0001437749-26-017292.md) | [6.5](/filings/0001437749-26-026209.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.4](/filings/0001437749-26-014294.md) | [2.2](/filings/0001213900-25-041331.md) | [2.2](/filings/0001437749-25-025334.md) | [2.1](/filings/0001437749-25-033534.md) | [2.1](/filings/0001437749-26-026209.md) | [0.4](/filings/0001437749-26-017292.md) | [0.4](/filings/0001437749-26-026209.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [221](/filings/0001213900-23-084614.md) | [197](/filings/0001213900-25-024009.md) | [193](/filings/0001213900-24-041190.md) | [202](/filings/0001213900-24-066525.md) | [211](/filings/0001213900-24-095312.md) | [246](/filings/0001437749-26-014294.md) | [198](/filings/0001213900-25-041331.md) | [197](/filings/0001437749-25-025334.md) | [199](/filings/0001437749-25-033534.md) | [251](/filings/0001437749-26-026209.md) | [252](/filings/0001437749-26-017292.md) | [262](/filings/0001437749-26-026209.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [31.8 d](/filings/0001213900-24-095312.md) | [10.5 d](/filings/0001437749-26-014294.md) | [12.9](/filings/0001213900-25-041331.md) | [20.4 d](/filings/0001437749-25-025334.md) | [24.4 d](/filings/0001437749-25-033534.md) | [13.0 d](/filings/0001437749-26-014294.md) | [15.3](/filings/0001437749-26-017292.md) | [1.1 d](/filings/0001437749-26-026209.md) | [13.9 d](/filings/0001437749-25-033534.md) | [15.9 d](/filings/0001437749-26-014294.md) | [(6.5)](/filings/0001437749-26-017292.md) | [(3.4) d](/filings/0001437749-26-026209.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001213900-24-095312.md) | not reported | [1.2](/filings/0001213900-25-041331.md) | [0.4 d](/filings/0001213900-24-066525.md) | [2.5 d](/filings/0001213900-24-095312.md) | not reported | [1.8](/filings/0001213900-25-041331.md) | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [2.1 d](/filings/0001213900-24-095312.md) | [2.1 d](/filings/0001437749-26-014294.md) | [2.1](/filings/0001213900-25-041331.md) | [2.0 d](/filings/0001213900-24-066525.md) | [2.0 d](/filings/0001213900-24-095312.md) | [2.0 d](/filings/0001437749-26-014294.md) | [2.0](/filings/0001213900-25-041331.md) | [2.0 d](/filings/0001437749-26-026209.md) | [2.0 d](/filings/0001437749-25-033534.md) | [2.0 d](/filings/0001437749-26-014294.md) | [2.0](/filings/0001437749-26-017292.md) | [2.0 d](/filings/0001437749-26-026209.md) |
| Share repurchases | $m | not reported | not reported | [4.1](/filings/0001213900-25-041331.md) | [1.8 d](/filings/0001213900-24-066525.md) | [2.0 d](/filings/0001213900-24-095312.md) | [2.5 d](/filings/0001213900-25-024009.md) | [1.9](/filings/0001213900-25-041331.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.2](/filings/0001213900-23-084614.md) | [26.6](/filings/0001213900-24-041190.md) | [26.3](/filings/0001213900-24-066525.md) | [27.4](/filings/0001213900-24-095312.md) | [27.3](/filings/0001213900-25-041331.md) | [27.0](/filings/0001437749-25-025334.md) | [26.9](/filings/0001437749-25-033534.md) | [26.6](/filings/0001437749-26-017292.md) | [26.5](/filings/0001437749-26-026209.md) | [26.4](/filings/0001437749-25-033534.md) | [26.1](/filings/0001437749-26-017292.md) | [26.2](/filings/0001437749-26-026209.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.